Dr. Reddy's to Release Q4 & Full Year FY12 Results on May 11, 2012

Earnings call slated for May 11, 6.30 PM IST / 9.00 AM EST

HYDERABAD, India--()--Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Fourth Quarter & Full Year ended March 31, 2012 on Friday, May 11, 2012 after the Board Meeting. The results will be available on the Company’s website www.drreddys.com.

Summary of Events

             

Event

   

Date and Time (IST)

   

Medium

Release of financial results May 11, after the Board Meeting Email, Media, Company website, Businesswire
Earnings Call May 11, 6.30 PM IST / 9:00 AM EST Hosted by the Company

(Details below)

Webcast of Earnings Call May 11, 6.30 PM IST / 9.00 AM EST through May 16, 2012

URL available on Company’s website,
www.drreddys.com

Transcripts of the Earnings call Will be available on the Company’s website

URL available on Company’s website,
www.drreddys.com

 

Earnings Call

Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance.

 

Conference Dial-In Numbers

Primary Number:     +91 22 6629 0356
Secondary Number:     +91 22 3065 0136
The numbers listed above are universally accessible from all networks and all countries.
Local Access Number:

6000 1221
Available in - Delhi, Bangalore, Chennai, Hyderabad, Kolkata
Accessible from all major carriers except BSNL/MTNL.
3940 3977
Available in - Gurgaon (NCR), Bangalore, Kolkata, Cochin, Pune,
Lucknow, Ahmedabad, Chandigarh
Accessible from all carriers.

International Toll Free Number: USA: 1 866 746 2133

UK: 0 808 101 1573

Singapore: 800 101 2045

Hong Kong: 800 964 448

No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.

Audio Webcast

The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through May 16, 2012. For play back dial in phone No: 022 3065 1212 and ID: 375#.

Transcript

The transcript of the earnings call will also be available on the Company's website.

About Dr. Reddy’s

Established in 1984, Dr. Reddy’s Laboratories (NYSE: RDY) is an emerging global pharmaceutical company. We fulfill our purpose of providing affordable and innovative medicines through three core businesses: Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. Our products are marketed globally, with a focus on India, US, UK, Germany and Russia.

Website: www.drreddys.com

Contacts

Dr. Reddy's Laboratories
Investor Relations:
Kedar Upadhye, +91 40 66834297
kedaru@drreddys.com
or
Raghavender R, +91 40 49002135
raghavenderr@drreddys.com
or
Saunak Savla, +91 40 49002135
saunaks@drreddys.com
or
Milan Kalawadia (USA), +1 9082034931
mkalawadia@drreddys.com

Sharing

Contacts

Dr. Reddy's Laboratories
Investor Relations:
Kedar Upadhye, +91 40 66834297
kedaru@drreddys.com
or
Raghavender R, +91 40 49002135
raghavenderr@drreddys.com
or
Saunak Savla, +91 40 49002135
saunaks@drreddys.com
or
Milan Kalawadia (USA), +1 9082034931
mkalawadia@drreddys.com